Medicure (TSE:MPH) has released an update.
TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Medicure Inc., specializing in pharmaceuticals for the U.S. market, has reported a slight increase in total net revenue, reaching $5.7 million for the first quarter of 2024, with Marley Drug business showing significant growth. The company also announced a successful election of its Board of Directors, with over 99% votes in favor of the listed nominees, including the addition of Kim Kline, a seasoned bioscience industry leader.
For further insights into TSE:MPH stock, check out TipRanks’ Stock Analysis page.